| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |